Soluble Mesothelin Related Peptides (MESOMARK®)
Also known as: MESO
Use
MESOMARK is an enzyme-linked immunosorbent assay for the quantitative measurement of soluble mesothelin-related peptides (SMRP) in serum. Measurement of SMRP may aid in the management of patients diagnosed with epithelioid or biphasic mesothelioma. Epidemiologic studies have established exposure to asbestos fibers as the primary cause of malignant mesothelioma. However, results obtained with different assay methods or kits cannot be used interchangeably, and results cannot be interpreted as absolute evidence of the presence or absence of malignant disease.
Special Instructions
This test is developed by ARUP Laboratories and performed in a CLIA-certified laboratory. It is New York approved but has not been cleared or approved by the US FDA. Ensure specimens are handled and processed according to the provided specimen preparation and stability guidelines.
Limitations
Results obtained from different assay methods or kits cannot be used interchangeably. The assay results cannot be interpreted as conclusive evidence for the presence or absence of malignant disease. As this is a laboratory developed test, it has not been cleared or approved by the FDA, and is intended for clinical use as per CLIA regulations.
New York Approved
Methodology
Immunoassay (ELISA)
Biomarkers
LOINC Codes
- 41292-4
Result Turnaround Time
1-8 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
Not provided
Minimum Volume
0.1 mL
Container
ARUP Standard Transport Tube
Collection Instructions
Allow specimen to clot completely at room temperature. Transfer 0.2 mL serum to an ARUP Standard Transport Tube.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Unacceptable |
| Refrigerated | 24 hours |
| Frozen | 3 months |